B.Riley cuts Energy Recovery stock price target on megaproject weakness

Energy Recovery reported Q3 2026 revenue of $11.2 million, below B.Riley’s $19.1 million estimate and the Street’s $16.1 million, while megaproject revenue fell 95% year over year to $0.9 million amid the ongoing Iran conflict; gross margin declined to 37.5% from 64.2%. B.Riley cut its price target to $7 from $8 and maintained a Neutral rating, despite about $30 million of new megaproject contracts in the past 30 days and backlog above $60 million. The company ended the quarter with $85.6 million in cash and no debt, and repurchased $2.4 million of shares during the quarter.

Analysis

ERII’s key risk is not balance-sheet solvency but earnings visibility: megaproject timing makes quarterly revenue and factory utilization highly volatile, so weak volume can compress margins sharply even if long-run unit economics remain intact. OEM/Aftermarket activity may cushion that volatility, but the article provides no segment-level evidence that it can offset delayed projects. The cash balance limits near-term financing risk; buybacks may support per-share value, but they cannot substitute for backlog conversion and could consume optionality if project timing slips.

Near term, Iran-related disruption is a catalyst for schedule changes, not proof of permanent demand destruction. Over 1–3 months, watch whether signed work converts into recognized revenue and whether gross margin rebounds with volume. The 2027 revenue visibility that includes active negotiations should be discounted versus signed backlog; treating it as contracted risks overvaluing a long-dated pipeline. Over 6–18 months, desalination investment could support ERII and broader water-infrastructure suppliers, but procurement and project execution cycles leave room for repeated deferrals.

The contrarian case is that the selloff may already reflect a prolonged trough, while a debt-free balance sheet provides time for demand to recover. Conversely, a backlog headline can obscure weak near-term conversion. With no independent evidence here on project schedules, cancellation terms, or OEM demand, the setup is not compelling enough for an outright short or an immediate long.

Key Decisions for Investors

• Keep ERII at neutral/watch rather than chasing the backlog announcement. Reassess after the next report: look for megaproject revenue conversion and a gross-margin recovery alongside it, not backlog growth alone.
• A staged long is only justified if the next 1–2 quarters show recognized project revenue and improving utilization without a material drawdown in cash from buybacks. Falsify the recovery thesis if signed projects are repeatedly deferred or margins remain depressed despite higher volume.
• Monitor the Iran-related project schedule, cancellation or deferral terms, and the split of backlog between signed contracts and negotiations; these are missing inputs that determine how much weight to assign to the 2027 outlook.
• Avoid a short based solely on the quarterly miss: substantial liquidity and the possibility of project catch-up create squeeze and recovery risk. Revisit downside exposure if guidance or backlog conversion weakens further, rather than relying on the analyst price-target change.